// App-Quantinova.ai

: Consolidation with Allogeneic Hematopoietic Cell Transplant Improved Survival Outcomes of Adults with Relapsed / Refractory Acute Lymphoblastic Leukemia Following Response to Memory-Enriched CD19CAR T Cells

Researchers

Presenter

  • Ibrahim Aldoss

Principal Investigators

  • Xiuli Wang

  • Joycelynne Palmer

  • Yan Wang

  • Jamie R. Wagner

  • Mary C. Clark

  • Jennifer Simpson

  • Jinny Paul

  • Vibhuti Vyas

  • Sheng-Hsuan Chien

  • Anthony S. Stein

  • Vinod A. Pullarkat

  • Amandeep Salhotra

  • Monzr M. Al Malki

  • Sandra Thomas

  • L. Elizabeth Budde

  • Guido Marcucci

  • Christine E. Brown

  • Stephen J. Forman

Medical Centers

  • Department of Hematology/HCT, City of Hope, Beckman Research Institute, Duarte, CA

  • Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

  • T Cell Therapeutics Laboratory, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

  • Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA

  • City of Hope, Duarte, CA

  • Gehr Family Leukemia Center, City of Hope, Duarte, CA

  • Department of Hematology and HCT, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA

  • Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope, Duarte, CA

  • Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA

  • Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, City of Hope Comprehensive Cancer Center, Duarte, CA

  • City of Hope National Medical Center, Duarte, CA

  • Department of Clinical and Translational Project Development, City of Hope, Duarte, CA

  • Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Coxsackie Virus And Adenovirus Receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Efficacy

  • Safety

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved